Summit X LLC’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-88,244
| Closed | -$227K | – | 237 |
|
|
2024
Q3 | $227K | Sell |
88,244
-151
| -0.2% | -$388 | 0.06% | 188 |
|
|
2024
Q2 | $227K | Buy |
88,395
+54,961
| +164% | +$141K | 0.05% | 214 |
|
|
2024
Q1 | $165K | Buy |
33,434
+16,046
| +92% | +$79K | 0.04% | 202 |
|
|
2023
Q4 | $153K | Sell |
17,388
-257
| -1% | -$2.26K | 0.04% | 185 |
|
|
2023
Q3 | $202K | Buy |
17,645
+858
| +5% | +$9.85K | 0.06% | 173 |
|
|
2023
Q2 | $425K | Sell |
16,787
-1,210
| -7% | -$30.6K | 0.1% | 172 |
|
|
2023
Q1 | $580K | Buy |
+17,997
| New | +$580K | 0.15% | 136 |
|